Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 9,679 shares at $230.76 ($2.2M) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Open-market sale of $2.2M NTRA by PRESIDENT, CLINICALDIAGNOSTICS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 180 | $0 | 0.0% |
| 2 | $230.76 | 4,692 | $1.1M | 50.0% |
| 3 | $230.76 | 4,692 | $1.1M | 50.0% |
| 4 | $0.00 | 115 | $0 | 0.0% |
| Total | $223.73 avg | 9,679 | $2.2M | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |